文献
J-GLOBAL ID:201802277076555087
整理番号:18A1593586
進行胃癌に対するファーストライン治療としてのカペシタビン+シスプラチン対S-1+シスプラチンの無作為化第II相試験: カペシタビン+シスプラチンastainment対S-1+シスプラチン無作為化PII試験(XPARTII)【JST・京大機械翻訳】
A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)
著者 (24件):
Nishikawa Kazuhiro
(Department of Surgery, Osaka National Hospital, Osaka, Japan)
,
Tsuburaya Akira
(Department of Surgery, Tsuboi Cancer Center Hospital, Koriyama, Japan)
,
Yoshikawa Takaki
(Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan)
,
Kobayashi Michiya
(Department of Human Health and Medical Science, Kochi Medical School, Nankoku, Japan)
,
Kawada Junji
(Department of Surgery, Osaka General Medical Center, Osaka, Japan)
,
Fukushima Ryoji
(Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan)
,
Matsui Takanori
(Department of Surgery, Aichi Cancer Center Aichi Hospital, Okazaki, Japan)
,
Tanabe Kazuaki
(Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan)
,
Yamaguchi Kazuya
(Department of Surgical Oncology, Gifu University, Gifu, Japan)
,
Yoshino Shigefumi
(Oncology Center, Yamaguchi University Hospital, Ube, Japan)
,
Takahashi Masazumi
(Division of Gastroenterological Surgery, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan)
,
Hirabayashi Naoki
(Department of Surgery, Hiroshima City Asa Hospital, Hiroshima, Japan)
,
Sato Seiji
(Department of Gastroenterological Surgery, Saga-Ken Medical Center Koseikan, Saga, Japan)
,
Nemoto Hiroshi
(Department of Surgery, Ebina General Hospital, Ebina, Japan)
,
Rino Yasushi
(Department of Surgery, Yokohama City University, Yokohama, Japan)
,
Nakajima Junta
(Department of 3rd Internal Medicine, Obihiro-Kosei General Hospital, Obihiro, Japan)
,
Aoyama Toru
(Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan)
,
Miyagi Yohei
(Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan)
,
Oriuchi Noboru
(Advanced Clinical Research Center, Fukushima Medical University, Fukushima, Japan)
,
Yamaguchi Kensei
(Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Miyashita Yumi
(Epidemiological & Clinical Research Information Network (ECRIN), Okazaki, Japan)
,
Morita Satoshi
(Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan)
,
Sakamoto Junichi
(Epidemiological & Clinical Research Information Network (ECRIN), Okazaki, Japan)
,
Sakamoto Junichi
(Tokai Central Hospital, Kakamigahara, Japan)
資料名:
European Journal of Cancer
(European Journal of Cancer)
巻:
101
ページ:
220-228
発行年:
2018年
JST資料番号:
A0802C
ISSN:
0959-8049
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)